A Phase 2 study to evaluate the efficacy and safety of T-817MA in patients with Alzheimer's Disease.
Phase 2
- Conditions
- Alzheimer's Disease
- Registration Number
- JPRN-jRCT2080222449
- Lead Sponsor
- Toyama Chemical Co., Ltd.(Current FUJIFILM Toyama Chemical Co., Ltd.)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients, whose age is between 55 and 90, taking donepezil hydrochloride, and diagnosed as mild to moderate Alzheimer's Disease according to the diagnostic criteria
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy, Safety
- Secondary Outcome Measures
Name Time Method